Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer cell

Showing results (1201-1210 of 3,827) with videos related to

Pageof 383
Sort By:
Cancer Cell|July 18, 2006
Removal of BRCA1/CtIP/ZBRK1 repressor complex on ANG1 promoter leads to accelerated mammary tumor growth contributed by prominent vasculatureSaori Furuta, Ju-Ming Wang, Shuanzeng Wei, et al.
Cancer Cell|July 18, 2006
HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitorsShizhen Emily Wang, Archana Narasanna, Marianela Perez-Torres, et al.
Cancer Cell|July 18, 2006
Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancerBin-Bing S Zhou, Michael Peyton, Biao He, et al.
Cancer Cell|July 18, 2006
Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesisKurt Degenhardt, Robin Mathew, Brian Beaudoin, et al.
Cancer Cell|August 15, 2006
Intracellular signaling in tumor and endothelial cells: The expected and, yet again, the unexpectedOliver Stoeltzing, Funda Meric-Bernstam, Lee M Ellis
Cancer Cell|August 15, 2006
Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycinThuy L Phung, Keren Ziv, Donnette Dabydeen, et al.
Cancer Cell|September 9, 2006
Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanateDunyaporn Trachootham, Yan Zhou, Hui Zhang, et al.
Cancer Cell|March 15, 2006
IRS-1: auditing the effectiveness of mTOR inhibitorsJohn B Easton, Raushan T Kurmasheva, Peter J Houghton
Cancer Cell|March 15, 2006
The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cellsJen-Liang Su, Pan-Chyr Yang, Jin-Yuan Shih, et al.
Cancer Cell|April 20, 2005
EGF receptor inhibition: attacks on multiple frontsStevan R Hubbard
Pageof 383

Showing results (1201-1210 of 3,827) with videos related to

Sort By:
Pageof 383
Cancer Cell|July 18, 2006
Removal of BRCA1/CtIP/ZBRK1 repressor complex on ANG1 promoter leads to accelerated mammary tumor growth contributed by prominent vasculatureSaori Furuta, Ju-Ming Wang, Shuanzeng Wei, et al.
Cancer Cell|July 18, 2006
HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitorsShizhen Emily Wang, Archana Narasanna, Marianela Perez-Torres, et al.
Cancer Cell|July 18, 2006
Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancerBin-Bing S Zhou, Michael Peyton, Biao He, et al.
Cancer Cell|July 18, 2006
Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesisKurt Degenhardt, Robin Mathew, Brian Beaudoin, et al.
Cancer Cell|August 15, 2006
Intracellular signaling in tumor and endothelial cells: The expected and, yet again, the unexpectedOliver Stoeltzing, Funda Meric-Bernstam, Lee M Ellis
Cancer Cell|August 15, 2006
Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycinThuy L Phung, Keren Ziv, Donnette Dabydeen, et al.
Cancer Cell|September 9, 2006
Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanateDunyaporn Trachootham, Yan Zhou, Hui Zhang, et al.
Cancer Cell|March 15, 2006
IRS-1: auditing the effectiveness of mTOR inhibitorsJohn B Easton, Raushan T Kurmasheva, Peter J Houghton
Cancer Cell|March 15, 2006
The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cellsJen-Liang Su, Pan-Chyr Yang, Jin-Yuan Shih, et al.
Cancer Cell|April 20, 2005
EGF receptor inhibition: attacks on multiple frontsStevan R Hubbard
Pageof 383